Xuefeng He

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Yue Song, Fei Zhou, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, De-Pei Wu, Xuefeng He
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal 14 (1) (2024)
Yue Song, Fei Zhou, Xiaoli Li, Feng Du, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, Depei Wu, Xuefeng He
Myelodysplastic syndrome associated-haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre. British journal of haematology (2023)